JAPMA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salk, R.
Right arrow Articles by Douglas, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salk, R.
Right arrow Articles by Douglas, T. S.
Journal of the American Podiatric Medical Association
Volume 96 Number 3 220-225 2006
Copyright © 2006 American Podiatric Medical Association

Intralesional Bleomycin Sulfate Injection for the Treatment of Verruca Plantaris

Robert Salk, DPM * and Troy S. Douglas, DPM {dagger}

* Northern California Foot and Ankle Center, San Francisco.
{dagger} Department of Podiatry, St Mary’s Medical Center, San Francisco, CA.

Corresponding author: Robert Salk, DPM, Northern California Foot and Ankle Center, 45 Castro St, Ste 315, San Francisco, CA 94114.

Abstract

Sixty-two patients were treated for single or multiple warts by intralesional injection of bleomycin sulfate (1.5 U/mL) and then were observed for 6 months. The dose varied according to the size of the lesion and ranged from 0.25 to 1.0 mL per injection per lesion, up to a maximum dose of 3 mL. The total cure rate was 87% after one or two injections. Twelve of the 62 patients required a second injection. (J Am Podiatr Med Assoc 96(3): 220–225, 2006)






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Podiatric Medical Association.